AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion.
暂无分享,去创建一个
Hui Zhao | Vladimir Jankovic | Ruud Delwel | S. Nimer | Hui Zhao | R. Delwel | P. Valk | M. Wunderlich | J. Mulloy | Stephen D Nimer | Peter J M Valk | Mark Wunderlich | James C Mulloy | J. Cammenga | V. Janković | O. Krejčí | B. Lowenberg | Bob Lowenberg | Ondrej Krejci | Jorg Cammenga
[1] Natalia Meani,et al. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. , 2003, The Journal of clinical investigation.
[2] R. Bronson,et al. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Downing,et al. AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.
[4] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Jakubowiak,et al. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1 , 1999, Oncogene.
[6] P. Boccuni,et al. Transcription factor fusions in acute leukemia: variations on a theme , 2002, Oncogene.
[7] M. Marín‐Padilla,et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Tomasson,et al. An activated receptor tyrosine kinase, TEL/PDGFβR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Licht,et al. The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein , 2000, Molecular and Cellular Biology.
[10] J. Downing,et al. Alterations of the AML1 transcription factor in human leukemia. , 2000, Seminars in cell & developmental biology.
[11] John M. Maris,et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.
[12] E. Macintyre,et al. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. , 2000, Blood.
[13] K. Tanaka,et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). , 1999, Blood.
[14] T. Kyo,et al. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. , 2004, Blood.
[15] P. Pandolfi,et al. The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia , 2002, Nature Medicine.
[16] S. Nakamura,et al. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. , 2000, Blood.
[17] C. von Kalle,et al. Murine Leukemia Induced by Retroviral Gene Marking , 2002, Science.
[18] N. Speck. Core binding factor and its role in normal hematopoietic development. , 2001, Current opinion in hematology.
[19] M. Caligiuri,et al. Identification and Characterization of an Activating TrkA Deletion Mutation in Acute Myeloid Leukemia , 2022 .
[20] T. Hoshino,et al. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] I. Weissman,et al. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[22] S. Jhanwar,et al. Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. , 2003, Blood.
[23] J. Downing,et al. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. , 2002, Cancer cell.
[24] J. Rowley,et al. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Tenen,et al. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. , 2000, Blood.
[26] D. Djakiew,et al. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines. , 1996, Journal of andrology.
[27] B. Hempstead,et al. Neurotrophins: novel mediators of angiogenesis. , 2003, Frontiers in bioscience : a journal and virtual library.
[28] D. Gilliland,et al. Signal transduction and transforming properties of the TEL–TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia , 2000, The EMBO journal.
[29] C. Glass,et al. ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors , 1998, Molecular and Cellular Biology.
[30] A. Warren,et al. Hematopoietic Stem Cell Expansion and Distinct Myeloid Developmental Abnormalities in a Murine Model of the AML1-ETO Translocation , 2002, Molecular and Cellular Biology.
[31] M. Ohki,et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1‐MTG8 fusion transcript. , 1993, The EMBO journal.
[32] J. Downing,et al. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. , 1998, Blood.
[33] C. Stocking,et al. AML1-ETO Inhibits Maturation of Multiple Lymphohematopoietic Lineages and Induces Myeloblast Transformation in Synergy with ICSBP Deficiency , 2002, The Journal of experimental medicine.
[34] F. Alt,et al. The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo , 1996, Cell.
[35] J. Zhang,et al. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. , 1995, Oncogene.
[36] Ping Ji,et al. Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells , 2004, Molecular and Cellular Biology.
[37] D. Littman,et al. Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte Development , 2002, Cell.
[38] S. Minucci,et al. Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO , 1998, Molecular and Cellular Biology.
[39] K. MacKenzie,et al. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. , 2002, Blood.
[40] T. Noda,et al. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[41] R. Verhaak,et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.
[42] E. Seto,et al. A Mechanism of Repression by Acute Myeloid Leukemia-1, the Target of Multiple Chromosomal Translocations in Acute Leukemia* , 2000, The Journal of Biological Chemistry.
[43] N. Lenny,et al. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation , 1995, Molecular and cellular biology.
[44] J. Rowley,et al. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. , 1993, Blood.
[45] T. Inaba,et al. Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia. , 2003, Blood.
[46] S. Chevalier,et al. Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells , 1994 .
[47] S. Chevalier,et al. Nerve growth factor is involved in the supportive effect by bone marrow--derived stromal cells of the factor-dependent human cell line UT-7. , 1996, Blood.
[48] A. Viale,et al. Induction of C/EBPalpha activity alters gene expression and differentiation of human CD34+ cells. , 2003, Blood.
[49] H. Yamasaki,et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. , 1999, Blood.
[50] J. Zhang,et al. The AML1/ETO fusion protein activates transcription of BCL-2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[51] P Dubus,et al. Expression of neurotrophins and their receptors in human bone marrow. , 1999, The American journal of pathology.